safinamide has been researched along with Restless Leg Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liguori, C; Mercuri, NB; Pierantozzi, M; Stefani, A | 1 |
| Chazot, PL | 1 |
1 review(s) available for safinamide and Restless Leg Syndrome
| Article | Year |
|---|---|
Safinamide for the treatment of Parkinson's disease, epilepsy and restless legs syndrome.
Topics: Alanine; Animals; Benzylamines; Clinical Trials as Topic; Epilepsy; Humans; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Restless Legs Syndrome | 2007 |
1 other study(ies) available for safinamide and Restless Leg Syndrome
| Article | Year |
|---|---|
Effective treatment of restless legs syndrome by safinamide in Parkinson's disease patients.
Topics: Alanine; Benzylamines; Female; Humans; Male; Middle Aged; Parkinson Disease; Restless Legs Syndrome; Treatment Outcome | 2018 |